Literature DB >> 21181357

The relationship of cystatin C, creatinine, estimated GFR, and cardiovascular events.

Luo Zhang1, Li Ni, Jiagao Lv.   

Abstract

This study examined the predictive value of plasma cystatin C, creatinine and estimated glomerular filtration rate (eGFR) as risk factors for cardiovascular disease in Chinese. Plasma cystatin C and creatinine were measured in 466 coronary heart disease (CHD) patients recruited from 4 hospitals and 349 healthy controls from local communities in Wuhan, China. Cockroft-Gault formula was used to estimate the glomerular filtration rate (GFR) after adjusting for body surface area. With each measure, the study population was divided into quintiles. The results showed that the patients had significantly higher levels of plasma cystatin C, creatinine, and lower level of eGFR than controls. Lower eGFR was associated with a higher risk of cardiovascular events. As compared with the first (highest) quintile, the hazard ratios (and 95% CIs) after multivariate adjustment for CHD were as follows: third quintile, 2.98 (1.54-5.78); fourth quintile, 3.34 (1.58-7.09); fifth quintile, 4.37(1.84-10.35). With higher cystatin C quintiles (≥1.00 mg/L and ≥1.17 mg/L), the hazard ratios for CHD were 2.16 (1.23-3.81) and 2.34 (1.25-4.38), similar to those of creatinine 2.21 (1.21-4.03) and 2.03 (1.07-3.84). However, it was plasma cystatin C not eGFR or creatinine had stronger association with ischemic stroke. The highest quintile had the hazard ratio of 4.51 (1.45-14.08) after multivariate adjustment. It was concluded that plasma cystatin C, associated with renal function, is not an independent risk factor for cardiovascular disease. eGFR is a better risk predictor for CHD than plasma cystatin C and creatinine. But for ischemic stroke, plasma cystatin C is a better risk factor than creatinine and estimated GFR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181357     DOI: 10.1007/s11596-010-0643-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  22 in total

1.  Plasma cystatin-C and development of coronary heart disease: The PRIME Study.

Authors:  Gérald Luc; Jean-Marie Bard; Céline Lesueur; Dominique Arveiler; Alun Evans; Philippe Amouyel; Jean Ferrieres; Irène Juhan-Vague; Jean-Charles Fruchart; Pierre Ducimetiere
Journal:  Atherosclerosis       Date:  2005-07-25       Impact factor: 5.162

2.  Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events.

Authors:  Michael Loew; Michael M Hoffmann; Wolfgang Koenig; Hermann Brenner; Dietrich Rothenbacher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-28       Impact factor: 8.311

Review 3.  Update on cystatin C: new insights into the importance of mild kidney dysfunction.

Authors:  Michael G Shlipak; Melanie L Praught; Mark J Sarnak
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-05       Impact factor: 2.894

4.  Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.

Authors:  Wolfgang Koenig; Dorothee Twardella; Hermann Brenner; Dietrich Rothenbacher
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

Review 5.  Cystatin C: an improved estimator of glomerular filtration rate?

Authors:  Omar F Laterza; Christopher P Price; Mitchell G Scott
Journal:  Clin Chem       Date:  2002-05       Impact factor: 8.327

6.  Biochemical indicators of cardiac and renal function in a healthy elderly population.

Authors:  Nina Johnston; Tomas Jernberg; Bertil Lindahl; Johan Lindbäck; Mats Stridsberg; Anders Larsson; Per Venge; Lars Wallentin
Journal:  Clin Biochem       Date:  2004-03       Impact factor: 3.281

7.  Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease.

Authors:  Per Eriksson; Hiroyuki Deguchi; Ann Samnegård; Pia Lundman; Susanna Boquist; Per Tornvall; Carl-Göran Ericsson; Lott Bergstrand; Lars-Olof Hansson; Shu Ye; Anders Hamsten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-15       Impact factor: 8.311

8.  Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

Authors:  Michael G Shlipak; Paul A Heidenreich; Haruko Noguchi; Glenn M Chertow; Warren S Browner; Mark B McClellan
Journal:  Ann Intern Med       Date:  2002-10-01       Impact factor: 25.391

9.  Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese.

Authors:  Li Ni; Jiagao Lü; Ling Bo Hou; Jiang Tao Yan; Qiao Fan; Rutai Hui; Katherine Cianflone; Wei Wang; Dao Wen Wang
Journal:  Stroke       Date:  2007-10-18       Impact factor: 7.914

10.  Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C.

Authors:  E Wasén; R Isoaho; K Mattila; T Vahlberg; S-L Kivelä; K Irjala
Journal:  J Intern Med       Date:  2004-07       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.